BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17504834)

  • 1. Rates of adverse events of long-acting opioids in a state Medicaid program.
    Hartung DM; Middleton L; Haxby DG; Koder M; Ketchum KL; Chou R
    Ann Pharmacother; 2007 Jun; 41(6):921-8. PubMed ID: 17504834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of long-acting opioid use and oral versus transdermal route among older Medicaid beneficiaries.
    Rigler SK; Shireman TI; Kallenbach L
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):91-9. PubMed ID: 17719511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
    Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of constipation associated with long-acting opioid therapy: a comparative study.
    Staats PS; Markowitz J; Schein J
    South Med J; 2004 Feb; 97(2):129-34. PubMed ID: 14982259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
    O'Connor AB; Zwemer FL; Hays DP; Feng C
    Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain.
    Kwong WJ; Diels J; Kavanagh S
    Ann Pharmacother; 2010 Apr; 44(4):630-40. PubMed ID: 20197473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain.
    Ray WA; Chung CP; Murray KT; Hall K; Stein CM
    JAMA; 2016 Jun; 315(22):2415-23. PubMed ID: 27299617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
    Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
    J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy switching in patients receiving long-acting opioids.
    Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
    Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
    Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ
    Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
    Sittl R; Nuijten M; Nautrup BP
    Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward evidence-based prescribing at end of life: a comparative analysis of sustained-release morphine, oxycodone, and transdermal fentanyl, with pain, constipation, and caregiver interaction outcomes in hospice patients.
    Weschules DJ; Bain KT; Reifsnyder J; McMath JA; Kupperman DE; Gallagher RM; Hauck WW; Knowlton CH
    Pain Med; 2006; 7(4):320-9. PubMed ID: 16898943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of opioids in the treatment of chronic non-cancer pain.
    Trescot AM; Glaser SE; Hansen H; Benyamin R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S181-200. PubMed ID: 18443639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
    Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.